Healthcare Sector Stocks
The Healthcare sector has a total of 1052 stocks, with a combined market cap of $8.9 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 44.54.
Market Cap
8.9T
Revenue
4.59T
Profits
199.82B
PE Ratio
44.54
Profit Margin
4.35%
Dividend Yield
0.40%
1053 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.03T | -1.34% | 817,580 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 612.83B | 1.58% | 3,958,952 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 447.75B | -1.04% | 2,247,892 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 393.98B | -0.58% | 2,455,682 | 450.13B |
| 5 | MRK | Merck & Co., Inc. | 315.50B | 1.17% | 3,896,852 | 65.77B |
| 6 | NVS | Novartis AG | 282.96B | -0.41% | 1,019,030 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 263.57B | -0.20% | 1,190,784 | 60.44B |
| 8 | NVO | Novo Nordisk A/S | 215.75B | -2.61% | 5,835,482 | 50.57B |
| 9 | AMGN | Amgen Inc. | 198.21B | 0.28% | 529,909 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 195.66B | 0.58% | 1,398,522 | 45.20B |
| 11 | ABT | Abbott Laboratories | 175.24B | 0.94% | 6,010,130 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 163.03B | 0.79% | 2,094,726 | 29.74B |
| 13 | PFE | Pfizer Inc. | 141.86B | -0.20% | 19,862,161 | 63.32B |
| 14 | CVS | CVS Health Corporation | 139.97B | -0.81% | 3,606,697 | 405.62B |
| 15 | DHR | Danaher Corporation | 125.90B | 0.05% | 7,028,019 | 25.11B |
| 16 | BMY | Bristol-Myers Squibb Company | 124.26B | -0.13% | 3,096,910 | 48.48B |
| 17 | ISRG | Intuitive Surgical, Inc. | 120.91B | -2.23% | 2,950,022 | 11.03B |
| 18 | VRTX | Vertex Pharmaceuticals Incorporated | 120.51B | -1.49% | 538,448 | 12.22B |
| 19 | SYK | Stryker Corporation | 119.34B | -1.05% | 842,046 | 25.27B |
| 20 | SNY | Sanofi | 105.26B | 0.34% | 2,160,636 | 54.60B |
| 21 | MDT | Medtronic plc | 104.71B | -0.67% | 2,129,907 | 36.36B |
| 22 | GSK | GSK plc | 101.79B | 0.26% | 2,771,001 | 43.29B |
| 23 | MCK | McKesson Corporation | 96.00B | -1.07% | 371,489 | 403.43B |
| 24 | ELV | Elevance Health, Inc. | 84.80B | -0.62% | 666,645 | 201.11B |
| 25 | HCA | HCA Healthcare, Inc. | 82.91B | 0.17% | 471,024 | 76.39B |
| 26 | CI | The Cigna Group | 76.29B | -0.72% | 772,264 | 277.89B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 66.68B | -2.93% | 443,522 | 14.92B |
| 28 | BSX | Boston Scientific Corporation | 63.74B | -0.71% | 5,913,917 | 20.61B |
| 29 | COR | Cencora, Inc. | 58.74B | -0.39% | 439,930 | 328.68B |
| 30 | TAK | Takeda Pharmaceutical Company Limited | 54.35B | -1.83% | 2,389,959 | 28.34B |
| 31 | ARGX | argenx SE | 54.26B | -1.74% | 117,505 | 4.74B |
| 32 | CAH | Cardinal Health, Inc. | 52.78B | -0.76% | 517,276 | 250.74B |
| 33 | MDLN | Medline Inc. | 49.12B | -4.35% | 2,954,040 | 29.14B |
| 34 | EW | Edwards Lifesciences Corporation | 48.55B | -0.28% | 2,256,147 | 6.30B |
| 35 | HUM | Humana Inc. | 47.95B | -1.22% | 347,685 | 137.20B |
| 36 | HLN | Haleon plc | 43.12B | -0.55% | 7,522,000 | 14.85B |
| 37 | IDXX | IDEXX Laboratories, Inc. | 43.07B | -1.17% | 181,149 | 4.45B |
| 38 | BDX | Becton, Dickinson and Company | 42.23B | -0.37% | 529,417 | 22.23B |
| 39 | RVMD | Revolution Medicines, Inc. | 39.03B | 0.17% | 539,501 | - |
| 40 | NTRA | Natera, Inc. | 37.83B | -1.14% | 419,495 | 2.50B |
| 41 | A | Agilent Technologies, Inc. | 37.79B | 0.71% | 1,434,836 | 7.23B |
| 42 | WAT | Waters Corporation | 36.44B | 0.98% | 550,580 | 3.77B |
| 43 | ONC | BeOne Medicines AG | 35.76B | 0.93% | 363,075 | 5.74B |
| 44 | ALNY | Alnylam Pharmaceuticals, Inc. | 35.55B | -1.89% | 541,361 | 4.29B |
| 45 | TEVA | Teva Pharmaceutical Industries Limited | 35.46B | -2.87% | 2,952,227 | 17.35B |
| 46 | RPRX | Royalty Pharma plc | 33.80B | 0.48% | 1,282,234 | 2.44B |
| 47 | IQV | IQVIA Holdings Inc. | 33.39B | -0.79% | 360,527 | 16.63B |
| 48 | ALC | Alcon Inc. | 32.92B | -0.30% | 742,091 | 10.63B |
| 49 | CNC | Centene Corporation | 32.91B | -1.39% | 1,909,423 | 178.33B |
| 50 | ZTS | Zoetis Inc. | 31.17B | -1.33% | 2,377,202 | 9.53B |
| 51 | VEEV | Veeva Systems Inc. | 29.91B | -2.70% | 657,049 | 3.32B |
| 52 | BIIB | Biogen Inc. | 29.68B | -1.05% | 280,555 | 9.94B |
| 53 | ILMN | Illumina, Inc. | 29.30B | 0.59% | 746,651 | 4.39B |
| 54 | GEHC | GE HealthCare Technologies Inc. | 28.07B | -0.55% | 1,517,061 | 20.98B |
| 55 | RMD | ResMed Inc. | 27.91B | -1.18% | 462,304 | 5.54B |
| 56 | DXCM | DexCom, Inc. | 27.61B | -4.26% | 1,676,064 | 4.82B |
| 57 | MTD | Mettler-Toledo International Inc. | 25.90B | -1.27% | 74,359 | 4.09B |
| 58 | PHG | Koninklijke Philips N.V. | 25.69B | -0.81% | 610,885 | 20.34B |
| 59 | WST | West Pharmaceutical Services, Inc. | 25.28B | -0.40% | 407,687 | 3.22B |
| 60 | ROIV | Roivant Sciences Ltd. | 25.10B | -0.20% | 1,703,947 | 8.26M |
| 61 | INSM | Insmed Incorporated | 23.36B | -0.76% | 898,278 | 819.56M |
| 62 | INCY | Incyte Corporation | 23.36B | -0.41% | 475,997 | 5.36B |
| 63 | BNTX | BioNTech SE | 23.23B | -0.51% | 287,780 | 3.23B |
| 64 | MRNA | Moderna, Inc. | 23.18B | -2.10% | 1,989,606 | 2.23B |
| 65 | LH | Labcorp Holdings Inc. | 23.03B | 0.54% | 337,810 | 14.14B |
| 66 | DGX | Quest Diagnostics Incorporated | 22.91B | 0.05% | 620,797 | 11.28B |
| 67 | UTHR | United Therapeutics Corporation | 22.47B | -1.22% | 278,583 | 3.17B |
| 68 | STE | STERIS plc | 20.57B | -0.34% | 272,074 | 5.94B |
| 69 | VTRS | Viatris Inc. | 19.94B | -2.64% | 6,274,719 | 14.56B |
| 70 | GH | Guardant Health, Inc. | 19.83B | -1.80% | 578,001 | 1.08B |
| 71 | GMAB | Genmab A/S | 17.91B | 2.12% | 1,137,904 | 3.90B |
| 72 | NBIX | Neurocrine Biosciences, Inc. | 17.61B | -2.19% | 678,724 | 3.10B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 17.12B | -0.51% | 481,054 | 8.41B |
| 74 | THC | Tenet Healthcare Corporation | 16.92B | -0.05% | 454,290 | 21.46B |
| 75 | ASND | Ascendis Pharma A/S | 16.75B | -0.43% | 208,299 | 998.25M |
| 76 | BBIO | BridgeBio Pharma, Inc. | 16.16B | -0.01% | 711,062 | 579.96M |
| 77 | JAZZ | Jazz Pharmaceuticals plc | 15.83B | -0.87% | 248,931 | 4.44B |
| 78 | MEDP | Medpace Holdings, Inc. | 15.13B | -0.37% | 261,867 | 2.68B |
| 79 | DVA | DaVita Inc. | 14.97B | -1.70% | 243,907 | 13.84B |
| 80 | BTSG | BrightSpring Health Services, Inc. | 14.80B | -2.12% | 1,211,934 | 13.65B |
| 81 | EXEL | Exelixis, Inc. | 13.92B | -1.35% | 870,996 | 2.38B |
| 82 | COO | The Cooper Companies, Inc. | 13.78B | -0.49% | 792,641 | 4.23B |
| 83 | SOLV | Solventum Corporation | 13.47B | -1.06% | 189,125 | 8.26B |
| 84 | FMS | Fresenius Medical Care AG | 12.96B | -1.13% | 224,115 | 22.32B |
| 85 | ELAN | Elanco Animal Health Incorporated | 12.92B | 1.53% | 2,674,747 | 4.89B |
| 86 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.82B | 22.11% | 5,446,931 | 622.01M |
| 87 | ICLR | ICON Public Limited Company | 12.79B | 0.19% | 342,900 | 8.27B |
| 88 | SNN | Smith & Nephew plc | 12.65B | -0.60% | 820,861 | 6.16B |
| 89 | PEN | Penumbra, Inc. | 12.46B | -0.23% | 337,807 | 1.45B |
| 90 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.44B | -1.32% | 186,255 | 1.13B |
| 91 | ALGN | Align Technology, Inc. | 12.43B | -2.24% | 273,768 | 4.10B |
| 92 | AXSM | Axsome Therapeutics, Inc. | 12.36B | 1.39% | 374,639 | 708.24M |
| 93 | RVTY | Revvity, Inc. | 12.35B | 0.20% | 856,807 | 2.90B |
| 94 | MOH | Molina Healthcare, Inc. | 11.59B | -1.75% | 1,178,935 | 43.10B |
| 95 | ABVX | ABIVAX Société Anonyme | 11.56B | -3.12% | 500,103 | 5.67M |
| 96 | SMMT | Summit Therapeutics Inc. | 11.48B | 1.09% | 2,789,713 | - |
| 97 | CYTK | Cytokinetics, Incorporated | 11.37B | 3.21% | 1,134,622 | 105.82M |
| 98 | BAX | Baxter International Inc. | 11.34B | -1.17% | 1,551,595 | 11.32B |
| 99 | BMRN | BioMarin Pharmaceutical Inc. | 11.32B | -1.05% | 850,797 | 3.24B |
| 100 | TECH | Bio-Techne Corporation | 11.19B | 0.24% | 1,392,130 | 1.21B |
| 101 | EHC | Encompass Health Corporation | 11.01B | -1.01% | 264,364 | 6.07B |
| 102 | PODD | Insulet Corporation | 10.98B | -3.20% | 893,233 | 2.90B |
| 103 | CRL | Charles River Laboratories International, Inc. | 10.62B | 0.49% | 257,952 | 4.03B |
| 104 | GMED | Globus Medical, Inc. | 10.28B | -0.46% | 414,039 | 3.10B |
| 105 | RDY | Dr. Reddy's Laboratories Limited | 10.21B | -8.12% | 2,600,926 | 3.50B |
| 106 | APGE | Apogee Therapeutics, Inc. | 10.08B | 0.05% | 708,609 | - |
| 107 | KRYS | Krystal Biotech, Inc. | 10.01B | 0.13% | 175,697 | 417.30M |
| 108 | CORT | Corcept Therapeutics Incorporated | 9.99B | -2.67% | 375,611 | 769.10M |
| 109 | ENSG | The Ensign Group, Inc. | 9.85B | -0.57% | 200,319 | 5.27B |
| 110 | HSIC | Henry Schein, Inc. | 9.67B | -1.18% | 401,669 | 13.38B |
| 111 | HALO | Halozyme Therapeutics, Inc. | 9.24B | -0.90% | 820,853 | 1.51B |
| 112 | KYMR | Kymera Therapeutics, Inc. | 9.20B | -1.37% | 182,020 | 51.48M |
| 113 | BRKR | Bruker Corporation | 9.16B | -0.45% | 838,040 | 3.46B |
| 114 | UHS | Universal Health Services, Inc. | 9.06B | -0.18% | 270,511 | 17.76B |
| 115 | OSCR | Oscar Health, Inc. | 8.99B | -2.96% | 1,931,696 | 13.30B |
| 116 | GKOS | Glaukos Corporation | 8.89B | -1.12% | 266,913 | 551.35M |
| 117 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.84B | -0.02% | 1,902,873 | 18.07M |
| 118 | IONS | Ionis Pharmaceuticals, Inc. | 8.84B | 0.22% | 6,268,424 | 1.06B |
| 119 | ALKS | Alkermes plc | 8.80B | -0.15% | 541,574 | 1.56B |
| 120 | SYRE | Spyre Therapeutics, Inc. | 8.79B | -2.67% | 281,575 | - |
| 121 | PRAX | Praxis Precision Medicines, Inc. | 8.74B | -1.42% | 128,731 | 7.46M |
| 122 | PTGX | Protagonist Therapeutics, Inc. | 8.73B | -1.87% | 315,169 | 74.06M |
| 123 | TEM | Tempus AI, Inc. | 8.43B | -4.14% | 2,987,740 | 1.36B |
| 124 | QGEN | Qiagen N.V. | 8.37B | -0.20% | 942,905 | 2.10B |
| 125 | ATR | AptarGroup, Inc. | 8.25B | 0.22% | 152,215 | 3.87B |
| 126 | BIO | Bio-Rad Laboratories, Inc. | 8.18B | 1.28% | 133,547 | 2.59B |
| 127 | PCVX | Vaxcyte, Inc. | 8.14B | -2.90% | 624,676 | - |
| 128 | HQY | HealthEquity, Inc. | 8.05B | -1.50% | 310,087 | 1.34B |
| 129 | IMVT | Immunovant, Inc. | 8.05B | -0.81% | 348,582 | - |
| 130 | RGEN | Repligen Corporation | 8.00B | 3.56% | 1,984,888 | 763.34M |
| 131 | IBRX | ImmunityBio, Inc. | 7.90B | -6.51% | 5,945,479 | 140.98M |
| 132 | LQDA | Liquidia Corporation | 7.68B | 6.71% | 2,499,926 | 288.07M |
| 133 | TGTX | TG Therapeutics, Inc. | 7.56B | -1.15% | 670,711 | 700.35M |
| 134 | AVTR | Avantor, Inc. | 7.50B | -0.05% | 3,710,664 | 6.55B |
| 135 | HIMS | Hims & Hers Health, Inc. | 7.34B | -3.12% | 5,566,452 | 2.37B |
| 136 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.11B | -2.73% | 215,610 | 217.17M |
| 137 | PACS | PACS Group, Inc. | 7.06B | -2.09% | 395,712 | 5.43B |
| 138 | MIRM | Mirum Pharmaceuticals, Inc. | 7.00B | -1.91% | 238,090 | 569.61M |
| 139 | LNTH | Lantheus Holdings, Inc. | 6.84B | -2.74% | 252,561 | 1.55B |
| 140 | ERAS | Erasca, Inc. | 6.83B | 1.57% | 1,821,626 | - |
| 141 | COGT | Cogent Biosciences, Inc. | 6.79B | 0.23% | 955,114 | - |
| 142 | CHE | Chemed Corporation | 6.66B | -0.02% | 100,722 | 2.54B |
| 143 | GRFS | Grifols, S.A. | 6.60B | 1.42% | 239,184 | 8.58B |
| 144 | PTCT | PTC Therapeutics, Inc. | 6.51B | -0.01% | 249,512 | 827.11M |
| 145 | XENE | Xenon Pharmaceuticals Inc. | 6.42B | -0.42% | 283,180 | 7.50M |
| 146 | CGON | CG Oncology, Inc. | 6.23B | -1.45% | 238,245 | 5.07M |
| 147 | BLTE | Belite Bio, Inc | 6.17B | -2.71% | 118,637 | - |
| 148 | HNGE | Hinge Health, Inc. | 6.16B | -5.67% | 1,490,303 | 646.34M |
| 149 | TXG | 10x Genomics, Inc. | 6.05B | 0.95% | 1,440,707 | 638.78M |
| 150 | LGND | Ligand Pharmaceuticals Incorporated | 6.02B | -0.47% | 131,537 | 274.48M |
| 151 | TFX | Teleflex Incorporated | 5.98B | 0.01% | 134,206 | 2.13B |
| 152 | BLLN | BillionToOne, Inc. | 5.93B | -2.76% | 365,013 | 354.54M |
| 153 | SRRK | Scholar Rock Holding Corporation | 5.88B | -3.50% | 1,164,466 | - |
| 154 | TWST | Twist Bioscience Corporation | 5.87B | -1.62% | 329,880 | 409.48M |
| 155 | DFTX | Definium Therapeutics, Inc. | 5.84B | -2.48% | 572,368 | - |
| 156 | DNTH | Dianthus Therapeutics, Inc. | 5.73B | -0.79% | 411,385 | 1.34M |
| 157 | AMRX | Amneal Pharmaceuticals, Inc. | 5.69B | -1.44% | 640,669 | 3.05B |
| 158 | BLCO | Bausch + Lomb Corporation | 5.69B | -0.25% | 160,993 | 5.21B |
| 159 | ORKA | Oruka Therapeutics, Inc. | 5.62B | -1.25% | 463,752 | - |
| 160 | STVN | Stevanato Group S.p.A. | 5.27B | 0.99% | 122,413 | 1.39B |
| 161 | TVTX | Travere Therapeutics, Inc. | 5.22B | -0.76% | 405,180 | 536.20M |
| 162 | SHC | Sotera Health Company | 4.92B | -0.92% | 1,614,180 | 1.19B |
| 163 | INDV | Indivior Pharmaceuticals, Inc. | 4.90B | -0.57% | 339,950 | 1.29B |
| 164 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.79B | -1.94% | 179,636 | 754.05M |
| 165 | RDNT | RadNet, Inc. | 4.73B | -2.73% | 305,582 | 2.14B |
| 166 | MANE | Veradermics, Incorporated | 4.67B | 2.03% | 216,009 | - |
| 167 | CRSP | CRISPR Therapeutics AG | 4.65B | -2.04% | 891,416 | 4.10M |
| 168 | VCYT | Veracyte, Inc. | 4.64B | -2.26% | 260,336 | 541.74M |
| 169 | MMED | MiniMed Group, Inc. | 4.53B | -3.41% | 574,375 | 3.10B |
| 170 | LEGN | Legend Biotech Corporation | 4.52B | -0.68% | 450,529 | 1.14B |
| 171 | CELC | Celcuity Inc. | 4.40B | -1.51% | 517,674 | - |
| 172 | CAI | Caris Life Sciences, Inc. | 4.39B | -1.34% | 1,001,033 | 907.29M |
| 173 | VKTX | Viking Therapeutics, Inc. | 4.38B | -0.61% | 793,027 | - |
| 174 | MMSI | Merit Medical Systems, Inc. | 4.35B | -0.73% | 218,231 | 1.54B |
| 175 | ALHC | Alignment Healthcare, Inc. | 4.33B | -2.56% | 1,645,365 | 4.26B |
| 176 | LIVN | LivaNova PLC | 4.32B | -1.53% | 177,849 | 1.43B |
| 177 | NVST | Envista Holdings Corporation | 4.30B | -1.93% | 1,016,560 | 2.81B |
| 178 | LFST | LifeStance Health Group, Inc. | 4.29B | -3.32% | 1,168,956 | 1.49B |
| 179 | ACAD | ACADIA Pharmaceuticals Inc. | 4.28B | -1.61% | 557,229 | 1.10B |
| 180 | RLAY | Relay Therapeutics, Inc. | 4.23B | 0.52% | 674,523 | 10.68M |
| 181 | EWTX | Edgewise Therapeutics, Inc. | 4.19B | -1.69% | 299,769 | - |
| 182 | TNGX | Tango Therapeutics, Inc. | 4.08B | -2.89% | 740,745 | 56.99M |
| 183 | CON | Concentra Group Holdings Parent, Inc. | 4.02B | -1.13% | 404,466 | 2.23B |
| 184 | WAY | Waystar Holding Corp. | 3.99B | -3.21% | 977,172 | 1.16B |
| 185 | ICUI | ICU Medical, Inc. | 3.97B | 0.11% | 79,390 | 2.16B |
| 186 | DYN | Dyne Therapeutics, Inc. | 3.83B | -2.81% | 6,616,204 | - |
| 187 | PBLS | Parabilis Medicines, Inc. | 3.80B | -0.73% | 168,238 | - |
| 188 | DNLI | Denali Therapeutics Inc. | 3.76B | -0.63% | 503,178 | - |
| 189 | ELVN | Enliven Therapeutics, Inc. | 3.75B | -1.07% | 149,426 | - |
| 190 | NAMS | NewAmsterdam Pharma Company N.V. | 3.73B | -1.41% | 392,392 | 22.57M |
| 191 | RCUS | Arcus Biosciences, Inc. | 3.72B | 0.41% | 374,787 | 236.00M |
| 192 | DOCS | Doximity, Inc. | 3.67B | -3.32% | 1,502,730 | 644.86M |
| 193 | ALMS | Alumis Inc. | 3.64B | -4.89% | 424,200 | 8.40M |
| 194 | OGN | Organon & Co. | 3.55B | 0.11% | 507,550 | 6.16B |
| 195 | GPCR | Structure Therapeutics Inc. | 3.55B | 1.11% | 368,933 | - |
| 196 | TLX | Telix Pharmaceuticals Limited | 3.54B | -5.04% | 157,218 | 803.79M |
| 197 | HAE | Haemonetics Corporation | 3.53B | -0.38% | 164,968 | 1.33B |
| 198 | ADPT | Adaptive Biotechnologies Corporation | 3.51B | -2.83% | 1,443,318 | 295.41M |
| 199 | BKD | Brookdale Senior Living Inc. | 3.50B | -3.59% | 2,496,440 | 3.00B |
| 200 | ARQT | Arcutis Biotherapeutics, Inc. | 3.49B | -1.20% | 347,034 | 415.62M |
| 201 | IRTC | iRhythm Holdings, Inc. | 3.48B | -2.95% | 177,415 | 787.85M |
| 202 | NHC | National HealthCare Corporation | 3.45B | -0.95% | 57,039 | 1.53B |
| 203 | OPCH | Option Care Health, Inc. | 3.34B | -1.71% | 761,155 | 5.67B |
| 204 | IDYA | IDEAYA Biosciences, Inc. | 3.34B | -2.47% | 269,104 | 225.27M |
| 205 | ITGR | Integer Holdings Corporation | 3.28B | 0.20% | 93,887 | 1.86B |
| 206 | ACHC | Acadia Healthcare Company, Inc. | 3.25B | -0.70% | 631,621 | 3.37B |
| 207 | PRVA | Privia Health Group, Inc. | 3.21B | -3.04% | 449,474 | 2.25B |
| 208 | GRAL | GRAIL, Inc. | 3.06B | -1.83% | 136,295 | 156.12M |
| 209 | WRBY | Warby Parker Inc. | 3.01B | -0.24% | 1,883,808 | 890.57M |
| 210 | RGC | Regencell Bioscience Holdings Limited | 3.00B | -0.17% | 235,001 | - |
| 211 | IRON | Disc Medicine, Inc. | 2.86B | -1.02% | 152,970 | - |
| 212 | MBX | MBX Biosciences, Inc. | 2.79B | -2.75% | 338,182 | - |
| 213 | QURE | uniQure N.V. | 2.78B | 0.75% | 484,694 | 18.09M |
| 214 | ESTA | Establishment Labs Holdings Inc. | 2.77B | -1.62% | 183,343 | 229.58M |
| 215 | RARE | Ultragenyx Pharmaceutical Inc. | 2.74B | -2.38% | 764,969 | 670.00M |
| 216 | SUPN | Supernus Pharmaceuticals, Inc. | 2.74B | -1.40% | 164,240 | 776.83M |
| 217 | CLDX | Celldex Therapeutics, Inc. | 2.71B | -3.25% | 1,057,668 | 865.00K |
| 218 | BEAM | Beam Therapeutics Inc. | 2.66B | -1.98% | 709,734 | 164.01M |
| 219 | XRAY | DENTSPLY SIRONA Inc. | 2.66B | -2.86% | 2,435,172 | 3.68B |
| 220 | ATAI | AtaiBeckley Inc. | 2.65B | 0.42% | 7,280,008 | 3.49M |
| 221 | KOD | Kodiak Sciences Inc. | 2.63B | -0.68% | 224,007 | - |
| 222 | VERA | Vera Therapeutics, Inc. | 2.62B | -1.64% | 446,087 | - |
| 223 | IMNM | Immunome, Inc. | 2.58B | 0.18% | 275,411 | 4.02M |
| 224 | GRDN | Guardian Pharmacy Services, Inc. | 2.53B | -2.18% | 74,387 | 1.46B |
| 225 | CLOV | Clover Health Investments, Corp. | 2.51B | -0.52% | 1,847,819 | 2.21B |
| 226 | TRVI | Trevi Therapeutics, Inc. | 2.48B | -3.74% | 774,569 | - |
| 227 | TARS | Tarsus Pharmaceuticals, Inc. | 2.48B | 0.84% | 570,490 | 535.08M |
| 228 | TMDX | TransMedics Group, Inc. | 2.47B | -3.96% | 484,552 | 635.89M |
| 229 | NRIX | Nurix Therapeutics, Inc. | 2.46B | 0.94% | 578,801 | 36.77M |
| 230 | PGNY | Progyny, Inc. | 2.45B | -3.10% | 528,956 | 1.29B |
| 231 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.43B | 1.59% | 1,523,540 | 885.72M |
| 232 | PHVS | Pharvaris N.V. | 2.42B | 0.61% | 179,111 | - |
| 233 | MLYS | Mineralys Therapeutics, Inc. | 2.39B | -1.31% | 223,355 | - |
| 234 | SLS | SELLAS Life Sciences Group, Inc. | 2.35B | -7.21% | 4,191,617 | - |
| 235 | KLRA | Kailera Therapeutics, Inc. | 2.34B | -2.06% | 400,085 | - |
| 236 | PBH | Prestige Consumer Healthcare Inc. | 2.34B | 0.55% | 189,085 | 1.09B |
| 237 | NKTR | Nektar Therapeutics | 2.33B | 0.31% | 284,598 | 55.63M |
| 238 | ZLAB | Zai Lab Limited | 2.30B | 0.10% | 152,361 | 453.28M |
| 239 | VCEL | Vericel Corporation | 2.30B | -2.28% | 200,284 | 292.09M |
| 240 | IOVA | Iovance Biotherapeutics, Inc. | 2.30B | -5.93% | 11,081,862 | 285.61M |
| 241 | PLSE | Pulse Biosciences, Inc. | 2.28B | 8.99% | 373,176 | 751.00K |
| 242 | COAG | Hemab Therapeutics Holdings, Inc. | 2.28B | 1.14% | 140,274 | - |
| 243 | LMAT | LeMaitre Vascular, Inc. | 2.26B | -1.67% | 177,294 | 256.28M |
| 244 | BHVN | Biohaven Ltd. | 2.24B | -3.93% | 1,009,681 | - |
| 245 | NUVB | Nuvation Bio Inc. | 2.16B | -3.73% | 3,913,438 | 143.05M |
| 246 | NEOG | Neogen Corporation | 2.15B | -0.60% | 540,029 | 870.56M |
| 247 | AGIO | Agios Pharmaceuticals, Inc. | 2.15B | -3.39% | 541,072 | 66.05M |
| 248 | MESO | Mesoblast Limited | 2.13B | -0.64% | 63,727 | 65.38M |
| 249 | VRDN | Viridian Therapeutics, Inc. | 2.12B | 0.26% | 1,181,124 | 70.92M |
| 250 | HTFL | HeartFlow, Inc. | 2.12B | -3.34% | 380,332 | 191.42M |
| 251 | AXGN | Axogen, Inc. | 2.09B | -2.33% | 520,862 | 238.11M |
| 252 | AVAH | Aveanna Healthcare Holdings Inc. | 2.07B | -2.52% | 887,239 | 2.52B |
| 253 | URGN | UroGen Pharma Ltd. | 2.07B | -3.11% | 283,775 | 140.49M |
| 254 | SION | Sionna Therapeutics, Inc. | 2.06B | -3.20% | 342,222 | - |
| 255 | HRMY | Harmony Biosciences Holdings, Inc. | 2.06B | -3.28% | 388,724 | 899.11M |
| 256 | MD | Pediatrix Medical Group, Inc. | 2.06B | -1.63% | 309,995 | 1.93B |
| 257 | PVLA | Palvella Therapeutics, Inc. | 2.04B | -1.15% | 79,482 | - |
| 258 | HCM | HUTCHMED (China) Limited | 2.04B | 0.09% | 32,543 | 548.51M |
| 259 | ADUS | Addus HomeCare Corporation | 2.03B | -1.93% | 111,482 | 1.45B |
| 260 | SGRY | Surgery Partners, Inc. | 2.03B | -3.93% | 491,290 | 3.34B |
| 261 | NBTX | Nanobiotix S.A. | 2.01B | 0.30% | 65,191 | 38.27M |
| 262 | AGL | agilon health, inc. | 2.01B | -4.27% | 120,103 | 5.82B |
| 263 | KARD | Kardigan, Inc. | 2.00B | -2.12% | 194,602 | - |
| 264 | ZBIO | Zenas BioPharma, Inc. | 2.00B | -1.98% | 773,924 | 10.00M |
| 265 | AMLX | Amylyx Pharmaceuticals, Inc. | 2.00B | -2.92% | 806,581 | -665.00K |
| 266 | RAPP | Rapport Therapeutics, Inc. | 1.99B | -2.11% | 117,824 | 20.00M |
| 267 | GHRS | GH Research PLC | 1.97B | 1.52% | 95,562 | - |
| 268 | GLUE | Monte Rosa Therapeutics, Inc. | 1.97B | -1.23% | 334,371 | 42.95M |
| 269 | AUPH | Aurinia Pharmaceuticals Inc. | 1.97B | -1.98% | 465,787 | 298.30M |
| 270 | CDNA | CareDx, Inc. | 1.97B | -1.01% | 594,773 | 412.82M |
| 271 | SNDX | Syndax Pharmaceuticals, Inc. | 1.95B | -2.87% | 614,174 | 217.17M |
| 272 | ADMA | ADMA Biologics, Inc. | 1.94B | -2.44% | 1,000,086 | 509.86M |
| 273 | ASTH | Astrana Health, Inc. | 1.93B | -5.59% | 263,189 | 3.53B |
| 274 | LKFT | Lakefront Biotherapeutics NV | 1.93B | -0.99% | 58,404 | 1.20B |
| 275 | OCUL | Ocular Therapeutix, Inc. | 1.92B | -2.02% | 1,071,114 | 52.04M |
| 276 | PGEN | Precigen, Inc. | 1.90B | -3.10% | 1,354,563 | 31.60M |
| 277 | OMCL | Omnicell, Inc. | 1.87B | -1.58% | 368,206 | 1.23B |
| 278 | UFPT | UFP Technologies, Inc. | 1.87B | -0.96% | 101,378 | 608.85M |
| 279 | SNDA | Sonida Senior Living, Inc. | 1.87B | -3.52% | 162,074 | 367.34M |
| 280 | TYRA | Tyra Biosciences, Inc. | 1.87B | -1.49% | 273,902 | - |
| 281 | DMRA | Damora Therapeutics, Inc. | 1.85B | -8.94% | 316,777 | - |
| 282 | WGS | GeneDx Holdings Corp. | 1.85B | 0.81% | 340,763 | 442.68M |
| 283 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.84B | 0.56% | 996,852 | 204.73M |
| 284 | BCAX | Bicara Therapeutics Inc. | 1.83B | -1.05% | 203,528 | - |
| 285 | NEO | NeoGenomics, Inc. | 1.82B | -3.18% | 895,878 | 745.97M |
| 286 | TSHA | Taysha Gene Therapies, Inc. | 1.81B | -0.09% | 752,346 | 7.47M |
| 287 | IMCR | Immunocore Holdings plc | 1.79B | 2.29% | 534,858 | 412.81M |
| 288 | ABCL | AbCellera Biologics Inc. | 1.79B | -2.01% | 1,458,772 | 79.21M |
| 289 | GENB | Generate Biomedicines, Inc. | 1.78B | -3.30% | 163,661 | 30.30M |
| 290 | NVCR | NovoCure Limited | 1.77B | -4.25% | 519,152 | 674.41M |
| 291 | STOK | Stoke Therapeutics, Inc. | 1.77B | -1.49% | 142,889 | 32.08M |
| 292 | AAPG | Ascentage Pharma Group International | 1.76B | 2.25% | 10,916 | 82.08M |
| 293 | ALMR | Alamar Biosciences, Inc. | 1.74B | -0.24% | 105,149 | 87.16M |
| 294 | FTRE | Fortrea Holdings Inc. | 1.72B | 1.42% | 430,793 | 2.71B |
| 295 | BHC | Bausch Health Companies Inc. | 1.71B | 1.55% | 1,208,259 | 10.53B |
| 296 | ATRC | AtriCure, Inc. | 1.70B | -2.81% | 396,613 | 552.16M |
| 297 | BFLY | Butterfly Network, Inc. | 1.69B | -5.28% | 4,241,824 | 102.92M |
| 298 | SRPT | Sarepta Therapeutics, Inc. | 1.69B | -1.39% | 1,320,047 | 2.18B |
| 299 | ZYME | Zymeworks Inc. | 1.68B | -2.16% | 182,198 | 81.26M |
| 300 | TRLV | Trulieve Cannabis Corp. | 1.67B | -3.24% | 284,559 | 1.17B |
| 301 | ANIP | ANI Pharmaceuticals, Inc. | 1.65B | -1.68% | 95,791 | 923.71M |
| 302 | HROW | Harrow, Inc. | 1.64B | 0.53% | 198,053 | 268.68M |
| 303 | MPLT | MapLight Therapeutics, Inc. | 1.62B | -4.71% | 158,400 | - |
| 304 | CMPS | COMPASS Pathways plc | 1.62B | -1.64% | 1,157,645 | - |
| 305 | HCSG | Healthcare Services Group, Inc. | 1.61B | -5.40% | 1,102,005 | 1.86B |
| 306 | TDOC | Teladoc Health, Inc. | 1.60B | -8.50% | 2,702,386 | 2.51B |
| 307 | RXRX | Recursion Pharmaceuticals, Inc. | 1.59B | -2.60% | 10,553,472 | 66.41M |
| 308 | INNV | InnovAge Holding Corp. | 1.59B | -0.93% | 122,360 | 949.17M |
| 309 | MAZE | Maze Therapeutics, Inc. | 1.59B | -2.08% | 112,523 | 20.00M |
| 310 | VIR | Vir Biotechnology, Inc. | 1.58B | -0.53% | 1,033,220 | 65.50M |
| 311 | ANAB | AnaptysBio, Inc. | 1.57B | -1.10% | 605,001 | 232.39M |
| 312 | INVA | Innoviva, Inc. | 1.57B | -1.25% | 238,429 | 420.69M |
| 313 | MLTX | MoonLake Immunotherapeutics | 1.57B | -5.43% | 570,726 | - |
| 314 | NTLA | Intellia Therapeutics, Inc. | 1.56B | -2.70% | 1,454,727 | 66.09M |
| 315 | ENOV | Enovis Corporation | 1.54B | -1.57% | 200,451 | 2.28B |
| 316 | BLFS | BioLife Solutions, Inc. | 1.53B | 7.50% | 8,723,274 | 101.66M |
| 317 | SEPN | Septerna, Inc. | 1.53B | 0.95% | 141,220 | 72.26M |
| 318 | XERS | Xeris Biopharma Holdings, Inc. | 1.52B | -4.67% | 1,546,115 | 314.85M |
| 319 | ARDT | Ardent Health, Inc. | 1.50B | -0.19% | 88,836 | 6.43B |
| 320 | IART | Integra LifeSciences Holdings Corporation | 1.48B | -0.16% | 241,996 | 1.64B |
| 321 | AHCO | AdaptHealth Corp. | 1.47B | -1.52% | 480,648 | 3.29B |
| 322 | PRGO | Perrigo Company plc | 1.46B | 1.05% | 1,434,154 | 4.18B |
| 323 | INSP | Inspire Medical Systems, Inc. | 1.46B | -3.30% | 280,287 | 915.25M |
| 324 | SVRA | Savara Inc. | 1.45B | -2.05% | 2,448,516 | - |
| 325 | AVBP | ArriVent BioPharma, Inc. | 1.44B | 9.16% | 388,247 | - |
| 326 | XNCR | Xencor, Inc. | 1.43B | -5.77% | 582,162 | 97.36M |
| 327 | ABSI | Absci Corporation | 1.42B | 0.60% | 1,165,580 | 1.84M |
| 328 | PNTG | The Pennant Group, Inc. | 1.40B | -2.58% | 105,429 | 1.02B |
| 329 | PAHC | Phibro Animal Health Corporation | 1.39B | 0.86% | 72,973 | 1.50B |
| 330 | PSNL | Personalis, Inc. | 1.36B | -3.65% | 1,437,065 | 64.52M |
| 331 | AKTS | Aktis Oncology, Inc. | 1.35B | -0.61% | 85,764 | 8.28M |
| 332 | FBRX | Forte Biosciences, Inc. | 1.34B | 8.22% | 373,839 | - |
| 333 | AMN | AMN Healthcare Services, Inc. | 1.33B | 0.53% | 219,342 | 3.42B |
| 334 | TRAX | First Tracks Biotherapeutics, Inc. | 1.32B | 1.45% | 397,366 | - |
| 335 | AHG | Akso Health Group | 1.32B | -3.50% | 4,183 | 14.84M |
| 336 | NVAX | Novavax, Inc. | 1.31B | -1.49% | 1,297,675 | 596.34M |
| 337 | OMDA | Omada Health, Inc. | 1.30B | -4.52% | 729,035 | 283.30M |
| 338 | AVLN | Avalyn Pharma Inc. | 1.29B | 0.31% | 175,895 | - |
| 339 | INBX | Inhibrx Biosciences, Inc. | 1.26B | -1.89% | 77,975 | 1.30M |
| 340 | KMTS | Kestra Medical Technologies, Ltd. | 1.26B | -3.37% | 217,142 | 95.13M |
| 341 | CNMD | CONMED Corporation | 1.26B | -0.41% | 331,969 | 1.37B |
| 342 | ARDX | Ardelyx, Inc. | 1.25B | -0.39% | 1,158,678 | 427.68M |
| 343 | ATEC | Alphatec Holdings, Inc. | 1.25B | -2.17% | 893,967 | 787.08M |
| 344 | IMTX | Immatics N.V. | 1.25B | -2.98% | 126,092 | 43.00M |
| 345 | AZTA | Azenta, Inc. | 1.24B | 1.32% | 255,556 | 596.48M |
| 346 | STAA | STAAR Surgical Company | 1.23B | 1.94% | 571,375 | 290.38M |
| 347 | AORT | Artivion, Inc. | 1.22B | 0.84% | 202,926 | 458.69M |
| 348 | IRMD | IRADIMED CORPORATION | 1.22B | 0.25% | 41,208 | 86.28M |
| 349 | ETON | Eton Pharmaceuticals, Inc. | 1.20B | 1.06% | 308,887 | 86.93M |
| 350 | MNKD | MannKind Corporation | 1.19B | -4.81% | 3,422,593 | 360.78M |
| 351 | DRTS | Alpha Tau Medical Ltd. | 1.19B | -1.01% | 523,919 | - |
| 352 | CRVS | Corvus Pharmaceuticals, Inc. | 1.18B | -3.39% | 285,830 | - |
| 353 | JBIO | Jade Biosciences, Inc. | 1.17B | -3.65% | 530,995 | - |
| 354 | AVNS | Avanos Medical, Inc. | 1.17B | - | 210,437 | 715.90M |
| 355 | TNDM | Tandem Diabetes Care, Inc. | 1.16B | -4.15% | 753,246 | 1.03B |
| 356 | SPTX | Seaport Therapeutics, Inc. | 1.14B | 1.33% | 29,266 | - |
| 357 | ALVO | Alvotech | 1.13B | -9.66% | 1,147,810 | 562.04M |
| 358 | COLL | Collegium Pharmaceutical, Inc. | 1.13B | -2.82% | 104,105 | 796.33M |
| 359 | MGTX | MeiraGTx Holdings plc | 1.13B | -2.60% | 176,267 | 79.76M |
| 360 | USPH | U.S. Physical Therapy, Inc. | 1.12B | -1.27% | 145,284 | 787.69M |
| 361 | SDGR | Schrödinger, Inc. | 1.12B | -0.53% | 359,369 | 254.91M |
| 362 | ORIC | ORIC Pharmaceuticals, Inc. | 1.12B | -0.51% | 596,552 | - |
| 363 | QDEL | QuidelOrtho Corporation | 1.11B | -0.79% | 559,231 | 2.66B |
| 364 | CGEM | Cullinan Therapeutics, Inc. | 1.10B | -0.94% | 298,826 | - |
| 365 | WVE | Wave Life Sciences Ltd. | 1.10B | -1.55% | 1,347,447 | 71.80M |
| 366 | CAPR | Capricor Therapeutics, Inc. | 1.09B | -4.50% | 873,657 | 11.13M |
| 367 | NUTX | Nutex Health Inc. | 1.08B | -6.81% | 78,308 | 879.95M |
| 368 | ANRO | Alto Neuroscience, Inc. | 1.07B | 1.29% | 190,329 | - |
| 369 | CERT | Certara, Inc. | 1.06B | -0.22% | 916,254 | 419.75M |
| 370 | EYPT | EyePoint, Inc. | 1.06B | -2.95% | 519,731 | 7.61M |
| 371 | CRON | Cronos Group Inc. | 1.05B | -0.18% | 636,213 | 159.54M |
| 372 | IVA | Inventiva S.A. | 1.04B | 2.15% | 388,643 | 7.94M |
| 373 | VOR | Vor Biopharma Inc. | 1.04B | -4.59% | 506,419 | - |
| 374 | LBRX | LB Pharmaceuticals Inc | 1.03B | 11.64% | 513,480 | - |
| 375 | LMRI | Lumexa Imaging Holdings, Inc. | 1.03B | -3.96% | 80,228 | 1.03B |
| 376 | PRCT | PROCEPT BioRobotics Corporation | 1.02B | -3.51% | 545,224 | 322.02M |
| 377 | GMRS | GMR Solutions Inc. | 1.01B | 0.46% | 104,156 | 5.83B |
| 378 | PCRX | Pacira BioSciences, Inc. | 1.00B | -1.09% | 224,870 | 734.86M |
| 379 | GDRX | GoodRx Holdings, Inc. | 999.09M | -2.32% | 433,921 | 787.89M |
| 380 | OLMA | Olema Pharmaceuticals, Inc. | 994.45M | -1.77% | 301,503 | - |
| 381 | BIOA | BioAge Labs, Inc. | 988.18M | -1.85% | 695,607 | 10.32M |
| 382 | LXRX | Lexicon Pharmaceuticals, Inc. | 983.90M | -6.93% | 2,521,091 | 69.64M |
| 383 | BVS | Bioventus Inc. | 979.03M | -1.35% | 253,159 | 576.30M |
| 384 | AVTX | Avalo Therapeutics, Inc. | 960.19M | -3.56% | 287,398 | 59.00K |
| 385 | JANX | Janux Therapeutics, Inc. | 950.75M | -4.12% | 503,751 | 13.73M |
| 386 | SANA | Sana Biotechnology, Inc. | 943.18M | -0.47% | 977,665 | - |
| 387 | KURA | Kura Oncology, Inc. | 933.91M | -3.40% | 382,126 | 71.64M |
| 388 | PHAR | Pharming Group N.V. | 930.25M | -0.91% | 1,729 | 369.49M |
| 389 | PHAT | Phathom Pharmaceuticals, Inc. | 929.33M | 4.00% | 903,088 | 204.89M |
| 390 | REPL | Replimune Group, Inc. | 923.40M | - | 972,533 | - |
| 391 | GERN | Geron Corporation | 907.75M | -1.74% | 4,508,879 | 196.12M |
| 392 | OPK | OPKO Health, Inc. | 894.78M | -2.07% | 2,902,625 | 581.12M |
| 393 | GLAS | Glass House Brands Inc. | 890.74M | -2.42% | 63,194 | 177.68M |
| 394 | INMD | InMode Ltd. | 877.73M | -0.59% | 268,335 | 374.64M |
| 395 | TALK | Talkspace, Inc. | 874.42M | - | 1,407,207 | 238.37M |
| 396 | TBPH | Theravance Biopharma, Inc. | 873.82M | 0.12% | 193,557 | 109.78M |
| 397 | ODTX | Odyssey Therapeutics, Inc. | 868.03M | -0.49% | 60,833 | 1.06M |
| 398 | ABUS | Arbutus Biopharma Corporation | 860.28M | -3.65% | 756,932 | 191.45M |
| 399 | AMPH | Amphastar Pharmaceuticals, Inc. | 856.73M | -0.82% | 255,377 | 720.53M |
| 400 | ANNX | Annexon, Inc. | 853.62M | -3.34% | 904,102 | - |
| 401 | DBVT | DBV Technologies S.A. | 828.78M | -5.34% | 154,473 | 5.04M |
| 402 | AVR | Anteris Technologies Global Corp. | 812.77M | -1.77% | 351,913 | 1.85M |
| 403 | SLDB | Solid Biosciences Inc. | 803.35M | -3.55% | 572,814 | - |
| 404 | HSTM | HealthStream, Inc. | 795.09M | -2.24% | 117,691 | 311.78M |
| 405 | ACRS | Aclaris Therapeutics, Inc. | 784.91M | -1.23% | 396,204 | 8.37M |
| 406 | AURA | Aura Biosciences, Inc. | 769.34M | -0.78% | 258,667 | - |
| 407 | DRUG | Bright Minds Biosciences Inc. | 765.45M | -1.49% | 148,438 | - |
| 408 | MNPR | Monopar Therapeutics Inc. | 752.41M | -1.10% | 362,393 | - |
| 409 | SIBN | SI-BONE, Inc. | 750.83M | -0.65% | 236,365 | 206.22M |
| 410 | CSTL | Castle Biosciences, Inc. | 747.94M | 0.61% | 179,261 | 339.92M |
| 411 | CTMX | CytomX Therapeutics, Inc. | 738.01M | -0.88% | 1,061,330 | 35.54M |
| 412 | CADL | Candel Therapeutics, Inc. | 737.10M | -1.57% | 463,266 | - |
| 413 | TENX | Tenax Therapeutics, Inc. | 736.74M | -8.27% | 1,192,961 | - |
| 414 | BBNX | Beta Bionics, Inc. | 736.60M | -6.19% | 970,551 | 110.24M |
| 415 | DSGN | Design Therapeutics, Inc. | 733.24M | -2.65% | 270,537 | - |
| 416 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 724.17M | 3.67% | 175,996 | - |
| 417 | FTH | Faeth Therapeutics, Inc. | 720.52M | -1.48% | 419,265 | - |
| 418 | NGNE | Neurogene Inc. | 718.96M | -1.64% | 36,034 | 925.00K |
| 419 | EVO | Evotec SE | 716.68M | -2.00% | 21,705 | 859.03M |
| 420 | CLYM | Climb Bio, Inc. | 715.18M | -4.66% | 307,448 | - |
| 421 | ZVRA | Zevra Therapeutics, Inc. | 714.70M | -2.89% | 496,850 | 122.29M |
| 422 | SSII | SS Innovations International, Inc. | 714.47M | -0.28% | 12,532 | 48.47M |
| 423 | OMER | Omeros Corporation | 713.62M | 3.46% | 787,243 | 9.89M |
| 424 | RIGL | Rigel Pharmaceuticals, Inc. | 710.66M | -2.29% | 183,669 | 299.77M |
| 425 | OCS | Oculis Holding AG | 702.31M | -2.76% | 167,102 | 1.40M |
| 426 | SGP | SpyGlass Pharma, Inc. | 682.04M | 0.64% | 59,421 | - |
| 427 | IMMX | Immix Biopharma, Inc. | 669.19M | -1.78% | 1,002,690 | - |
| 428 | GYRE | Gyre Therapeutics, Inc. | 658.90M | -2.48% | 62,356 | 117.05M |
| 429 | BWAY | BrainsWay Ltd. | 654.34M | 1.36% | 91,586 | 56.22M |
| 430 | ACHV | Achieve Life Sciences, Inc. | 648.81M | -2.77% | 471,830 | - |
| 431 | CBLL | CeriBell, Inc. | 643.32M | -5.23% | 303,417 | 95.07M |
| 432 | CBIO | Crescent Biopharma, Inc. | 643.00M | -6.49% | 147,583 | 11.88M |
| 433 | IRWD | Ironwood Pharmaceuticals, Inc. | 641.99M | -0.26% | 605,906 | 361.51M |
| 434 | ALLO | Allogene Therapeutics, Inc. | 635.08M | -0.54% | 2,667,914 | 22.00K |
| 435 | RGNX | REGENXBIO Inc. | 631.84M | -0.97% | 611,083 | 87.82M |
| 436 | EVH | Evolent Health, Inc. | 631.58M | -4.02% | 972,949 | 1.89B |
| 437 | CERS | Cerus Corporation | 625.15M | - | 1,148,349 | 216.56M |
| 438 | TCMD | Tactile Systems Technology, Inc. | 623.23M | -2.81% | 134,026 | 343.52M |
| 439 | MDXG | MiMedx Group, Inc. | 621.10M | -3.47% | 446,338 | 389.42M |
| 440 | CRMD | CorMedix Inc. | 620.55M | -3.42% | 485,822 | 400.05M |
| 441 | SPRY | ARS Pharmaceuticals, Inc. | 616.67M | -2.36% | 2,165,287 | 98.99M |
| 442 | PHR | Phreesia, Inc. | 616.26M | -5.94% | 357,441 | 495.59M |
| 443 | NVCT | Nuvectis Pharma, Inc. | 608.44M | 1.15% | 101,185 | - |
| 444 | TECX | Tectonic Therapeutic, Inc. | 596.17M | -3.67% | 59,389 | - |
| 445 | CTKB | Cytek Biosciences, Inc. | 587.60M | -0.44% | 272,878 | 204.17M |
| 446 | ANGO | AngioDynamics, Inc. | 582.79M | -0.84% | 262,499 | 320.17M |
| 447 | FDMT | 4D Molecular Therapeutics, Inc. | 577.65M | -2.86% | 501,957 | 88.24M |
| 448 | AGMB | AgomAb Therapeutics NV | 577.19M | 0.69% | 57,227 | - |
| 449 | CTNM | Contineum Therapeutics, Inc. | 557.62M | 7.30% | 124,312 | - |
| 450 | SLBT | SL Science Holding Limited | 555.99M | -8.51% | 70,201 | 3.36M |
| 451 | FLGT | Fulgent Genetics, Inc. | 554.66M | -1.76% | 125,826 | 320.35M |
| 452 | PRME | Prime Medicine, Inc. | 554.50M | -1.60% | 1,246,487 | 4.03M |
| 453 | ALT | Altimmune, Inc. | 549.39M | 0.18% | 1,460,504 | 36.00K |
| 454 | SOPH | SOPHiA GENETICS SA | 537.77M | -1.38% | 414,159 | 81.18M |
| 455 | SLN | Silence Therapeutics plc | 536.11M | 4.61% | 524,143 | 839.00K |
| 456 | MYGN | Myriad Genetics, Inc. | 535.52M | -4.06% | 332,189 | 829.00M |
| 457 | ARVN | Arvinas, Inc. | 532.30M | -0.12% | 382,136 | 89.40M |
| 458 | EIKN | Eikon Therapeutics, Inc. | 530.56M | -1.11% | 183,713 | - |
| 459 | STTK | Shattuck Labs, Inc. | 529.48M | -4.23% | 454,860 | 1.00M |
| 460 | TOI | The Oncology Institute, Inc. | 527.91M | -2.76% | 1,093,988 | 545.76M |
| 461 | RLMD | Relmada Therapeutics, Inc. | 522.35M | -6.04% | 965,040 | - |
| 462 | ANL | Adlai Nortye Ltd. | 519.60M | -0.08% | 120,998 | 5.00M |
| 463 | RZLT | Rezolute, Inc. | 518.16M | -2.55% | 477,125 | - |
| 464 | VSTM | Verastem, Inc. | 515.38M | -2.25% | 744,652 | 49.59M |
| 465 | ASMB | Assembly Biosciences, Inc. | 515.25M | -1.78% | 72,652 | 71.10M |
| 466 | DNA | Ginkgo Bioworks Holdings, Inc. | 514.10M | -0.25% | 309,103 | 151.40M |
| 467 | ZURA | Zura Bio Limited | 513.94M | -4.75% | 288,243 | - |
| 468 | NPCE | NeuroPace, Inc. | 506.29M | -3.95% | 66,336 | 99.53M |
| 469 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 470 | TLRY | Tilray Brands, Inc. | 503.37M | -0.47% | 1,761,772 | 858.28M |
| 471 | AQST | Aquestive Therapeutics, Inc. | 501.87M | -0.99% | 1,022,007 | 50.27M |
| 472 | KIDS | OrthoPediatrics Corp. | 496.75M | -0.77% | 70,629 | 243.30M |
| 473 | HELP | Cybin Inc. | 494.01M | -1.60% | 1,725,173 | - |
| 474 | ARTV | Artiva Biotherapeutics, Inc. | 487.83M | 0.40% | 312,677 | 251.00K |
| 475 | WEAV | Weave Communications, Inc. | 487.74M | -9.85% | 992,819 | 248.72M |
| 476 | NRC | NRC Health | 484.76M | 0.14% | 30,711 | 138.64M |
| 477 | PROK | ProKidney Corp. | 469.70M | -2.51% | 293,549 | 889.00K |
| 478 | VALN | Valneva SE | 461.30M | -0.61% | 7,013 | 180.25M |
| 479 | VMD | Viemed Healthcare, Inc. | 458.51M | 0.34% | 162,913 | 286.57M |
| 480 | CLPT | ClearPoint Neuro, Inc. | 455.24M | -1.49% | 179,401 | 40.61M |
| 481 | OFIX | Orthofix Medical Inc. | 451.51M | -3.96% | 87,803 | 825.37M |
| 482 | VREX | Varex Imaging Corporation | 450.97M | -0.19% | 141,926 | 857.50M |
| 483 | KYTX | Kyverna Therapeutics, Inc. | 449.28M | -1.20% | 311,517 | - |
| 484 | PRTA | Prothena Corporation plc | 445.26M | -2.80% | 318,580 | 57.94M |
| 485 | CABA | Cabaletta Bio, Inc. | 444.32M | -3.37% | 1,033,138 | - |
| 486 | OVID | Ovid Therapeutics Inc. | 440.47M | -2.07% | 688,151 | 7.12M |
| 487 | SRTA | Strata Critical Medical, Inc. | 440.42M | -1.36% | 352,537 | 228.58M |
| 488 | SGMT | Sagimet Biosciences Inc. | 440.29M | 0.85% | 568,979 | - |
| 489 | OCGN | Ocugen, Inc. | 438.39M | -0.38% | 2,214,862 | 4.47M |
| 490 | CTEV | Claritev Corporation | 435.06M | -11.05% | 89,935 | 978.76M |
| 491 | DCTH | Delcath Systems, Inc. | 434.63M | -1.72% | 187,430 | 90.44M |
| 492 | PACB | Pacific Biosciences of California, Inc. | 428.63M | -1.43% | 5,794,203 | 160.03M |
| 493 | CCRN | Cross Country Healthcare, Inc. | 428.06M | 0.08% | 2,328,581 | 1.00B |
| 494 | CYH | Community Health Systems, Inc. | 427.36M | -1.71% | 558,599 | 12.29B |
| 495 | LRMR | Larimar Therapeutics, Inc. | 425.36M | 3.69% | 981,343 | - |
| 496 | EDIT | Editas Medicine, Inc. | 422.79M | -4.67% | 634,129 | 38.69M |
| 497 | EPRX | Eupraxia Pharmaceuticals Inc. | 416.65M | 0.94% | 753,823 | - |
| 498 | SI | Shoulder Innovations, Inc. | 416.53M | -3.44% | 40,481 | 53.89M |
| 499 | PBYI | Puma Biotechnology, Inc. | 414.32M | -5.13% | 217,451 | 227.18M |
| 500 | EVMN | Evommune, Inc. | 411.69M | -6.46% | 207,529 | 10.00M |